Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma

CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression

(2012) Zhifeng Miao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prognostic Factors in Patients With Advanced Renal Cell Carcinoma

(2012) Carolina Muriel López et al.   Clinical Genitourinary Cancer

Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor Progression

(2012) Zixuan Li et al.   PLoS One

CARMA3 is Crucial for EGFR-Induced Activation of NF- B and Tumor Progression

(2011) T. Jiang et al.   CANCER RESEARCH

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CXCL12/SDF‐1α Activates NF‐κB and Promotes Oral Cancer Invasion through the Carma3/Bcl10/Malt1 Complex

(2010) Aasia O Rehman et al.   International Journal of Oral Science

Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-κB activation

(2009) Daniela Marasco et al.   BIOCHEMICAL JOURNAL

Platelet-activating factor-induced NF-κB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent

(2009) Alip Borthakur et al.   INFLAMMATORY BOWEL DISEASES

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

(2009) Robert J. Motzer et al.   JOURNAL OF CLINICAL ONCOLOGY

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

(2008) Kiran Gupta et al.   CANCER TREATMENT REVIEWS